These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6483843)

  • 1. [Effectiveness of pyrazinamide combined with rifampicin and ethambutol in animal experiments].
    Tynystanova RI; Kozlova NV
    Probl Tuberk; 1984 Jul; (7):59-63. PubMed ID: 6483843
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy].
    Kekkaku; 1972 Dec; 47(12):457-66. PubMed ID: 4652424
    [No Abstract]   [Full Text] [Related]  

  • 3. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interactions of reserve antitubercular agents in combined administration].
    Korotaev GA; Kozulitsyna TM
    Probl Tuberk; 1978 Sep; (9):56-60. PubMed ID: 704600
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 6. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental study of schedules for intermittent administration of rifampicin and ethambutol].
    Kozulitsyna TI; Petrov IV
    Probl Tuberk; 1976 May; (5):72-5. PubMed ID: 951412
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bacteriologic results of treatment with rifampicin and ethambutol administered continuously or intermittently in experimental tuberculosis in white mice].
    Sosnowski W; Tomaszkiewicz L
    Gruzlica; 1973 Mar; 41(3):213-24. PubMed ID: 4696134
    [No Abstract]   [Full Text] [Related]  

  • 9. Tuberculosis treatment: dangerous regimens?
    Rieder HL; Arnadottir T; Trébucq A; Enarson DA
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapeutic effect and pharmacokinetics of rifampicin and ethambutol].
    Drabkina RO; Ginzburg TS
    Probl Tuberk; 1975; (3):69-74. PubMed ID: 1135208
    [No Abstract]   [Full Text] [Related]  

  • 11. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
    Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
    Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
    Grumbach F
    Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rifampicin combined with ethambutol and other antitubercular agents in the treatment of patients with chronic pulmonary tuberculosis. Early results. II. Analysis of causes of treatment interruption].
    Masztalerz J
    Pneumonol Pol; 1976 Feb; 44(2):153-61. PubMed ID: 940788
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacokinetic aspects of tuberculosis therapy with a fixed combination of rifampicin, isoniazide and pyrazinamide].
    Schaberg T; Lode H
    Z Gesamte Inn Med; 1991 Jun; 46(8):276-9. PubMed ID: 1897286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rifampicin and ethambutol treatment experience in chronic destructive pulmonary tuberculosis].
    Petrova GN; Sedunova EA; Korotaeva TA
    Probl Tuberk; 1981 Mar; (3):73-4. PubMed ID: 7232397
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combined rifampicin-ethambutol therapy of resistent pulmonary tuberculosis. Effectiveness of various rifampicin doses in combination with ethambutol].
    Hetrick C; Ras R; Turri M
    Dtsch Med Wochenschr; 1970 Sep; 95(36):1830-3. PubMed ID: 5453003
    [No Abstract]   [Full Text] [Related]  

  • 17. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative clinical evaluation of the treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin by the daily and intermittent methods].
    Zierski M; Bek E; Bergson H; Kucharska A; Strupczewska-Janusz H
    Pneumonol Pol; 1977 Apr; 45(4):277-90. PubMed ID: 854460
    [No Abstract]   [Full Text] [Related]  

  • 19. [Controlled rifampicin and ethambutol therapy of chronic destructive pulmonary tuberculosis in a rural district].
    Stoianovskiĭ EA; Abrarov BA; Iusman ZI; Ganiev AG; Mirzakhalov DK
    Probl Tuberk; 1976; (8):29-31. PubMed ID: 137403
    [No Abstract]   [Full Text] [Related]  

  • 20. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.